WFH Clinical Research Grant Program

Grant criteria and conditions

The WFH Clinical Research Grant Program will award up to four grants per year, for the best proposals that address critical clinical issues of broad international significance.

Grant amount/duration

  • $10,000-$50,000 per year, per grant
  • Funding is awarded for up to two years


The program is open to applicants, from all countries, who are affiliated with a recognized medical, scientific, or academic institution*, hemophilia or inherited bleeding disorder treatment centre, or WFH national member organization (NMO) or its affiliated chapters.

*PhD students are not eligible; the principle investigator must hold a faculty position at a recognized medical, scientific, or academic institution.

Selection criteria

WFH Clinical Research Grants will be awarded to projects that best align with the following criteria:

  • Importance of the research for clinical management of inherited bleeding disorders
  • Feasibility for generating new information
  • Novelty of the research objectives
  • Experience of the investigator/team of investigators
  • Soundness of the study design
  • Feasibility of completing the research within proposed timeframe and budget

The grant competition is open to a broad range of topics relating to the clinical management of inherited bleeding disorders. Ideally, the research question should be of interest and be of significant benefit to bleeding disorders patients that are represented by the WFH. 

The WFH Medical Advisory Board and the WFH Research Committee have identified research priorities that are strongly encouraged. Please note that this list is intended to provide guidance of the type of research proposals that might be submitted. Submissions do not need to be limited to this list.

Research priorities 

  1. Prophylaxis schedules
  2. Inhibitor diagnosis and management
  3. Optimal use of adjunctive therapies
  4. Care of the neonate with hemophilia
  5. Management of chronic hemophilic arthropathy
  6. Care of hemophilia carriers
  7. Pain management
  8. Role of physical activity in hemophilia care
  9. Management of special bleeds (e.g. ileopsoas, renal)
  10. Role of arthrocentesis in hemophilia care
  11. Management of cardiovascular disease in hemophilia
  12. von Willebrand disease and rare bleeding disorders


  • Applications must be submitted in English.
  • Submitted research projects must receive appropriate approval by a national/institutional Research Ethics Board prior to disbursement of funds. A copy of any required Research Ethics Board approval letter must be received before the first payment is transferred.
  • The grant funds must contribute towards the direct costs of the research program or project for which the funds were awarded.This can include staff (but does not include investigator or clinic staff salaries), equipment, materials and supplies. It does not include: investigator salary, Research Ethics Board approval fee, travel expenses, or clinic reimbursements. A maximum of 8% indirect (overhead) costs can be paid to the investigator’s institution, if required.
  • Two-year grants will be disbursed in two annual payments and will be sent to the financial officer of the host institution.
  • Applicants who receive funds must acknowledge the support of the WFH Clinical Research Grant Program in all the publications and oral presentations relating to the funded research.
  • To ensure continued funding for the second year, a one-page progress report is required. A final report is required upon completion of the research project.

Updated July 2016

The WFH Clinical Research Grant Program was supported by funding from: